JPH05502512A - オリゴヌクレオチドの非特異的結合を用いるβ―アミロイドタンパク質の検出方法 - Google Patents

オリゴヌクレオチドの非特異的結合を用いるβ―アミロイドタンパク質の検出方法

Info

Publication number
JPH05502512A
JPH05502512A JP51494291A JP51494291A JPH05502512A JP H05502512 A JPH05502512 A JP H05502512A JP 51494291 A JP51494291 A JP 51494291A JP 51494291 A JP51494291 A JP 51494291A JP H05502512 A JPH05502512 A JP H05502512A
Authority
JP
Japan
Prior art keywords
amyloid
oligonucleotides
detecting
precursor
amyloid protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51494291A
Other languages
English (en)
Japanese (ja)
Inventor
シルヤネン，スティナ
シルヤネン，カリ
ヘイノネン，オウティ
リエキネン，パアヴォ
Original Assignee
ローカス―ジェネックス　オイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ローカス―ジェネックス　オイ filed Critical ローカス―ジェネックス　オイ
Publication of JPH05502512A publication Critical patent/JPH05502512A/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP51494291A 1990-09-27 1991-09-27 オリゴヌクレオチドの非特異的結合を用いるβ―アミロイドタンパク質の検出方法 Pending JPH05502512A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI904766A FI904766A (fi) 1990-09-27 1990-09-27 Foerfarande foer detektering av protein.
FI904766 1990-09-27

Publications (1)

Publication Number Publication Date
JPH05502512A true JPH05502512A (ja) 1993-04-28

Family

ID=8531126

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51494291A Pending JPH05502512A (ja) 1990-09-27 1991-09-27 オリゴヌクレオチドの非特異的結合を用いるβ―アミロイドタンパク質の検出方法

Country Status (5)

Country Link
EP (1) EP0503022A1 (fi)
JP (1) JPH05502512A (fi)
CA (1) CA2069731A1 (fi)
FI (1) FI904766A (fi)
WO (1) WO1992006376A1 (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ242955A (en) * 1991-06-13 1995-01-27 Ici Plc Dna containing gene sequences corresponding to sequences causing alzheimers disease, detection, recombinant yeast with such code

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0274826B1 (en) * 1986-11-17 1998-08-12 Scios Inc. Recombinant Alzheimer's amyloid protein

Also Published As

Publication number Publication date
EP0503022A1 (en) 1992-09-16
WO1992006376A1 (en) 1992-04-16
CA2069731A1 (en) 1992-03-28
FI904766A0 (fi) 1990-09-27
FI904766A (fi) 1992-03-28

Similar Documents

Publication Publication Date Title
Shui et al. Biosensors for Alzheimer's disease biomarker detection: a review
Salon et al. Relationship between β-amyloid degradation and the 26S proteasome in neural cells
Forloni et al. Protein misfolding in Alzheimer’s and Parkinson’s disease: genetics and molecular mechanisms
KR100282031B1 (ko) 아밀로이드 전구체 단백질의 단백질 가수분해에 근거한 알츠하이머병의 진단분석
US5252463A (en) Clipsin, a chymotrypsin-like protease and method of using same
JP4454230B2 (ja) β−セクレターゼ基質及びその使用
WO2013181618A2 (en) Methods to treat alzheimer's disease using apoe inhibitors
Sandbrink et al. APP gene family: unique age-associated changes in splicing of Alzheimer's βA4-amyloid protein precursor
IL195288A (en) Methods for identifying Alzheimer's disease
US20090023145A1 (en) Methods of diagnosing or prognosing Alzheimer's disease
JP2001513777A (ja) アルツハイマー病の処置または予防のために効果的な薬物をスクリーニングするためのトランスジェニック動物および細胞株
US7014854B2 (en) Method for retarding or precluding Alzheimer's dementia
Kumaran et al. DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders
US20070199080A1 (en) Diagnostic and therapeutic use of F-box proteins for Alzheimer's disease and related neurodegenerative disorders
JPH05502512A (ja) オリゴヌクレオチドの非特異的結合を用いるβ―アミロイドタンパク質の検出方法
WO2000078934A2 (en) Use of the ubiquitin specific protease usp25 in the diagnosis and treatment of alzheimer's disease
WO1999060122A1 (fr) Methode d'examen des maladies du snc et de criblage des remedes associes
Calenda et al. Identification of a unique apolipoprotein E allele inMicrocebus murinus; apoe brain distribution and co-localization with β-amyloid and tau proteins
Chambers et al. Amyloid-β injection in rat amygdala alters tau protein but not mRNA expression
Bourbonnière et al. Enhanced Expression of Amyloid Precursor Protein in Response to Dibutyryl Cyclic AMP Is Not Mediated by the Transcription Factor AP‐2
Gerhard Analysis of the brain vasculature in a novel mouse model of HTRA1-related cerebral small vessel disease
Jabłkowski et al. New type of BACE1 siRNA delivery to cells
JP2000511408A (ja) 新規治療
WO2001040804A2 (en) Clearance of aberrant protein in correlation with disease
US20040157225A1 (en) Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders